Clinical characteristics of pediatric tumor-induced osteomalacia: a systematic review and individual patient data analysis
Frontiers in Endocrinology · 21.07.2026 · 17
DOI: 10.3389/fendo.2026.1871968 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Endocrinology, online erschienen am 21.07.2026. Verfasst von Rong Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Neoplasms, Connective Tissue, Paraneoplastic Syndromes, Osteomalacia, Neoplasms, Connective and Soft Tissue. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Pediatric tumor-induced osteomalacia (TIO), also called Tumor-induced rickets (TIR), is characterized by renal phosphate wasting, resulting in hypophosphatemia and rickets. This study aimed to evaluate the clinical characteristics of pediatric TIO patients.
Methods
A systematic search was performed on December 26, 2025, in PubMed, Elsevier, SpringerLink, the China National Knowledge Infrastructure, and Wanfang Data using the terms: “tumor-induced rickets,” “tumor-induced hypophosphatemic rickets,” “oncogenic osteomalacia,” “hypophosphatemia,” “tumor-induced osteomalacia,” “children,” “child,” and “pediatrics”. Studies published in English and Chinese were included. This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria.
Results
A total of 62 pediatric TIO cases were included. Pediatric TIO was more frequent in males, who exhibited a higher proportion of weakness and deformities compared with females. 16.1% of patients were misdiagnosed with another condition. Somatostatin receptor-based imaging modalities demonstrated a high proportion for identifying these tumors. Pediatric TIO-causing neoplasms were predominantly located in the lower extremities and primarily originated from the bone tissue. Benign tumors were more common than malignant ones. The latter were associated with lower serum calcium levels. Surgery is the preferred definitive treatment for pediatric TIO, with an 84.2% resolution proportion.
Conclusion
Pediatric TIO affects males more frequently than females, with male patients exhibiting a higher proportion of weakness and deformities, and is prone to misdiagnosis. Neoplasms are mostly located in the lower extremities and are predominantly benign. Surgery is the preferred treatment for pediatric TIO. For hypophosphatemic pediatric patients, TIO should be considered to preventing adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
- Department of Metabolic Endocrinology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, China.
- Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Zitieren
APA
Chen, R., Wen, Z., Cheng, C., Li, X., Wang, J., Liu, H., & Chen, H. (2026). Clinical characteristics of pediatric tumor-induced osteomalacia: a systematic review and individual patient data analysis. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1871968
Vancouver
Chen R, Wen Z, Cheng C, Li X, Wang J, Liu H, et al. Clinical characteristics of pediatric tumor-induced osteomalacia: a systematic review and individual patient data analysis. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1871968
BibTeX
@article{Chen2026,
author = {Chen, Rong and Wen, Zhangxin and Cheng, Cheng and Li, Xinping and Wang, Jingyi and Liu, Hong and Chen, Hailing},
title = {Clinical characteristics of pediatric tumor-induced osteomalacia: a systematic review and individual patient data analysis},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
doi = {10.3389/fendo.2026.1871968}
}
EUVIMED